Skip to content

Amanda W Baker

6 papers in the library · 24 citations · publishing 2020-2026

Papers

Sort Most recent Most cited

Effects of MBSR and escitalopram on self-compassion in anxiety disorders.

Journal of Psychiatric Research June 1, 2026 Amanda W Baker, Samantha R Philip, Caroline H Armstrong et al.

Self-compassion is recognized as important for psychological well-being and has been linked to reduced anxiety levels. Mindfulness-based interventions, such as the 8-week Mindfulness-Based Stress Reduction program (MBSR), have shown promise in treating anxiety disorders, but no studies to date have compared the effects of MBSR to the gold-standard medication treatment (escitalopram) on...

A randomized controlled trial comparing mindfulness to escitalopram for anxiety: In-person and remote, synchronous delivery pre and post COVID-19 pandemic.

Journal of Affective Disorders September 1, 2025 Elizabeth A Hoge, Mihriye Mete, Amanda W Baker et al. 3 citations

During the pandemic, a randomized controlled trial (RCT) of Mindfulness-Based Stress Reduction (MBSR) versus the antidepressant, escitalopram (ESC) added a second phase using a synchronous, videoconference (VC) format for both interventions, enabling randomized and naturalistic comparisons. The original in-person RCT demonstrated non-inferiority of MBSR to ESC. In the second phase, we...

DOI: 10.1016/j.jad.2025.04.145 (opens in new tab) Full text (opens in new tab) Mindfulness Anxiety disorders Comparative effectiveness Escitalopram +1

Changes in mindfulness facets across yoga, CBT and stress education in individuals with generalized anxiety disorder.

Journal of Mood and Anxiety Disorders June 1, 2024 Danielle Moskow Diamond, David Rosenfield, Nikki Kaiser et al. 5 citations

Improving mindfulness is an important treatment target for generalized anxiety disorder (GAD). However, less is known about how different treatments impact specific aspects of mindfulness. In a clinical trial (Simon et al., 2021), 226 individuals with GAD were randomized to 12 weeks of Kundalini Yoga (KY), cognitive behavioral therapy (CBT) or stress education (SE). To examine whether specific...

Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial.

JAMA Psychiatry January 1, 2023 Elizabeth A Hoge, Eric Bui, Mihriye Mete et al.

Anxiety disorders are common, highly distressing, and impairing conditions. Effective treatments exist, but many patients do not access or respond to them. Mindfulness-based interventions, such as mindfulness-based stress reduction (MBSR) are popular and can decrease anxiety, but it is unknown how they compare to standard first-line treatments. To determine whether MBSR is noninferior to...

Psychedelic science in post-COVID-19 psychiatry

Irish Journal of Psychological Medicine August 19, 2020 John R. Kelly, Matthew Crockett, Laith Alexander et al. 16 citations

The medium- to long-term consequences of COVID-19 are not yet known, though an increase in mental health problems are predicted. Multidisciplinary strategies across socio-economic and psychological levels may be needed to mitigate the mental health burden of COVID-19. Preliminary evidence from the rapidly progressing field of psychedelic science shows that psilocybin therapy offers a promising...